Database of patients with cervical cancer at Institut Paoli Calmettes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on creating a comprehensive database of patients diagnosed with cervical cancer at the Institut Paoli Calmettes. The database will collect and organize clinical data to better understand the disease and improve patient outcomes. By gathering detailed information on patient demographics, treatment regimens, and outcomes, the study aims to facilitate future research and enhance clinical practices related to cervical cancer.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient with a diagnosis of cervical cancer

Exclusion Criteria:

* Non applicable

Where it's running

• Institut Paoli Calmettes
  Marseille, Bouches du Rhone, France Recruiting

Study contacts

• Study coordinator: Dominique Genre, MD
• Email: drci.up@ipc.unicancer.fr
• Phone: 0033491223778

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Enlonstobart with chemotherapy and radiotherapy for locally advanced cervical cancer

  This study tests whether adding Enlonstobart to standard chemotherapy and chemoradiotherapy helps patients with locally advanced cervical cancer by increasing response rates and monitoring safety.

  Recruiting at 2 sites Phase 4 Tianjin Medical University Cancer Institute and Hospital · Tianjin and 1 other locations · NCT07776821

• Methylscape test in body fluids for multi-cancer detection in Colombia

  A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07741435

• Immunotherapy Plus Carbon Ion Radiotherapy for Locally Advanced Cervical Cancer

  This trial tests whether adding immunotherapy and chemotherapy to carbon ion radiotherapy can help women with locally advanced cervical cancer live longer without the cancer growing.

  Recruiting Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT07702838

• Dual PD1/CTLA4 immunotherapy with chemotherapy before surgery for locally advanced cervical cancer

  This study tests a combo of a PD1/CTLA4 bispecific antibody with standard chemotherapy to see if it can improve outcomes before surgery in women with locally advanced cervical cancer.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong · NCT07646301

• Radiomic MRI model to predict response to chemoradiotherapy in locally advanced cervical cancer

  This project tests whether MRI-based radiomic features can predict how women with locally advanced cervical cancer will respond to combined chemotherapy and radiation.

  Recruiting Centre Hospitalier Universitaire de Nīmes · Nîmes, Gard · NCT07305727

• Post-therapy stress symptoms after gynecologic brachytherapy in cervical cancer

  This study tests whether patients undergoing uterovaginal brachytherapy for cervical cancer develop post-traumatic stress symptoms and how these symptoms change over up to 5 years.

  Recruiting at 2 sites Centre Paul Strauss · Pierre-Bénite and 1 other locations · NCT07204535

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.